Renovascular disease history and symptoms

	Renovascular disease Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Renovascular disease from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Renovascular disease history and symptoms On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Renovascular disease history and symptoms All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Renovascular disease history and symptoms
CDC on Renovascular disease history and symptoms
Renovascular disease history and symptoms in the news
Blogs on Renovascular disease history and symptoms
Directions to Hospitals Treating Renovascular disease
Risk calculators and risk factors for Renovascular disease history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

“

CLASS I

Onset of hypertension before the age of 30 years or severe hypertension after age 55; level of evidence B
Accelerated, resistant, or malignant hypertension; level of evidence C
Development of new azotemia or worsening renal function after administration of an ACE inhibitor or ARB agent; level of evidence B
Uneaplained atrophic kidney or sizse discrepancy between kidnyes of >1.5cm; level of evidence B
Sudden, unexplained pulmonary edema; level of evidence B

CLASS IIa

Unexplained renal dysfunction, including individuals starting renal replacement therapy; level of evidence B

CLASS IIb

”